SILVER SPRING, Md., May 4, 2011/PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today released its final guidance to firms that manufacture, market, or distribute over-the-counter (OTC) liquid drug products packaged with cups, droppers, syringes, and spoons to measure and dispense the doses of medication.
The guidance, titled Dosage Delivery Devices for Orally Ingested OTC Liquid Drug Products, describes how easy-to-use dosage delivery devices and devices that minimize the risk of unintentional overdose can be provided for OTC medicines such as liquid pain relievers, cold medicine, cough syrups, and digestion aids.
"Accidental medication overdose in young children is an increasingly common, but preventable public health problem," said Karen Weiss, M.D., program director for the Center for Drug Evaluation and Research's Safe Use Initiative.
The FDA issued the guidance because of ongoing concerns about the potential accidental drug overdoses that can result from the use of dosage delivery devices with markings that are confusing, unclear or inconsistent with the labeled dosage directions.
Key recommendations in the guidance include:
- Dosage delivery devices should be included for all orally ingested OTC liquid drug products
- Devices should be marked with calibrated units of liquid measurement (e.g., teaspoon, tablespoon, or milliliter) that are the same as the units of liquid measure specified in the directions for the product and there should not be any unnecessary markings
- Manufacturers should ensure that dosage delivery devices are used only with the products they are packaged with
- Liquid measure markings on dosage delivery devices should be clearly visible and not obscured when the liquid product is added to the device.
According to the FDA, parents and caregivers should follow 10 tips when giving medicine to an infant or child:
- Always read and follow the Drug Facts label on your OTC medicine.
- Know the 'active ingredient' in your child's medicine.
- Give the right medicine, in the right amount, to your child.
- Talk to your doctor, pharmacist, or nurse to find out what mixes well and what doesn't.
- Use the dosing tool that comes with the medicine, such as a dropper or a dosing cup.
- Know the difference between a tablespoon and a teaspoon.
- Know your child's weight.
- Prevent a poison emergency by always using a child-resistant cap.
- Store all medicines in a safe place.
- Check the medicine three times.
The FDA recommends that anyone with questions about dosage delivery devices or how to measure liquid OTC medicines contact a physician, pharmacist, or other health care professional.
Health care professionals and patients are encouraged to report adverse events, side effects, or product quality problems to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
- Complete and submit the report online: www.fda.gov/MedWatch/report.htm
- Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 800-FDA-0178
For more information:
Dosage Delivery Devices for Orally Ingested OTC Liquid Drug Products
Kids Aren't Just Small Adults
FDA's Safe Use Initiative: Collaborating to Reduce Preventable Harm from Medications
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
Media Inquiries: Shelly Burgess, 301-796-4651, email@example.com
Consumer Inquiries: 888-INFO-FDA
Related medicine technology :1
|SOURCE U.S. Food and Drug Administration|
Copyright©2010 PR Newswire.
All rights reserved
. Dehaier Medical Chairman and CEO Issues Letter to Shareholders2
. Omni Bio Pharmaceutical, Incs. CEO Issues Letter to Shareholders3
. The Centers For Medicare and Medicaid Services Issues Advance Guidance to Part D Plan Sponsors Allowing the Use of Generic Sampling as Medicare Part D Drug Utilization Management Tool.4
. New FDLIs Food and Drug Policy Forum Focuses on Liability Issues in Vaccine Design Defect Claims5
. UBM TechInsights Issues Warning to Medical Devices Industry About Possible Obsolescence as Reliance on Smartphones Increases6
. Qualitest Pharmaceuticals Issues Voluntary, Nationwide Recall of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg / 500 mg, NDC 0603-3888-20, 60 Count, Lot Numbers T150G10B, T120J10E and T023M10A and Phenobarbital Tablets, USP 32.4 mg, ND7
. Viral Genetics Issues 2010 Year in Review, 2011 Outlook8
. S&P Equity Research Issues Health Care Sector Predictions for 20119
. FDA Issues Complete Response Letter Regarding Acetadote® Supplemental New Drug Application for Acute Liver Failure10
. Extreme Makeover for Healthcare Next Year? PwC Publishes its Top Health Industry Issues for 201111
. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations